EXT1 p.Arg340His
c.1019G>A · rs119103287 · VCV265129
Computational evidence
| Protein change | ||
| AlphaMissense | 0.9881 | likely pathogenic ✓ concordant with ClinVar |
|---|---|---|
| REVEL | 0.836 | moderately pathogenic-leaning |
| SaProt | LLR -8.90 | tolerated |
| ⇒ AlphaMissense and REVEL call this damaging; SaProt does not. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 7.7 | GERP 1.7, phastCons 1 |
| Regional constraint | o/e 0.75 | unconstrained · MANE · 280 kb · p 4.8e-06 · regional, not allelic |
| Overall | ||
| CADD | 33.0 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| African / African-Americangrpmax | 0.00133% | 75,024 |
| European (non-Finnish) | 0.000254% | 393,303 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- EXT1
- Protein
- p.Arg340His
- Coding
- c.1019G>A
- MANE Select
- NM_000127
- dbSNP
- rs119103287
- Type
- single nucleotide variant
- Location
- chr8:117837145 (GRCh38)
- Gene constraint
- LOEUF 0.339 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
- Structure
- AlphaFold pLDDT 84.67 · 6 PDB
- Residue 340
- a UniProt-annotated variant site (in ext1; decreased glucuronosyl-n-acetylglucosaminyl-proteoglycan 4-alpha-n-acetylglucosaminyltransferase activity; decreased n-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity; loss of heparan sulfate proteoglycan biosynthetic process; no effect on interaction with ext2; can be integrated in heparan sulfate polymerase complex); a UniProt-annotated variant site (in ext1); a UniProt-annotated variant site (in ext1; loss of heparan sulfate proteoglycan biosynthetic process); a β-strand
Disease context
exostoses, multiple, type 1 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: hereditary multiple osteochondromas
For Multiple osteochondromas (Orphanet):
- Inheritance
- Autosomal dominant
- Onset
- Childhood
- Prevalence
- >1 / 1000 (Specific population)
Similar variants
- EXT1 p.Arg340Cys Pathogenic/Likely pathogenic ★★ same residue
- EXT1 p.Arg340Gly Pathogenic/Likely pathogenic ★★ same residue
- EXT1 p.Arg340Leu Pathogenic ★★ same residue
- EXT1 p.Arg340= Benign ★ same residue
- EXT1 c.1056+1G>A Pathogenic ★★ same condition
- EXT1 c.1056+1G>T Pathogenic ★★ same condition
- EXT1 c.1165-1G>A Pathogenic ★★ same condition
- EXT1 c.1285-1G>C Pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ext1-p-arg340his (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown